Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Trial details
- Registry ID
- NCT05789056
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT05789056 | Quoin Pharmaceuticals | Phase 2, Phase 3 | Recruiting | 2026-12-30Estimated |
| Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT06953466 | Quoin Pharmaceuticals | Phase 2, Phase 3 | Recruiting | 2026-12-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |